Literature DB >> 9183334

Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience.

M A Sloan1, T R Price, M L Terrin, S Forman, J M Gore, B R Chaitman, M Hodges, H Mueller, W J Rogers, G L Knatterud, E Braunwald.   

Abstract

BACKGROUND AND
PURPOSE: Ischemic cerebral infarction (CI) is a serious complication of acute myocardial infarction (MI). Little information exists on CI after thrombolytic therapy for MI.
METHODS: Of 3924 MI patients treated with recombinant tissue plasminogen activator (rt-PA) and heparin, 29 (0.7%) developed CI after treatment. All CI patients had detailed neurological evaluations, and 27 (93%) had CT scans centrally reviewed.
RESULTS: Age range was 40 to 74 years (mean, 60 years); 25 patients (86%) were men, and 22 (76%) were white. The electrocardiographic location of MI was anterior in 22 (76%) and nonanterior in 7 (24%). Five CIs occurred within 6 hours, 4 between 6 to 24 hours, 8 during the remainder of the first week, 10 during the second week, and 2 others distributed over the 4 weeks after study entry. Six of 29 CIs did not involve the cerebral cortex; 9 patients (31%) had multiple CIs. Of 28 CIs thought to be embolic in origin, 17 showed strong evidence for at least one cardiac abnormality (mural clot, wall-motion abnormality, aneurysm, or atrial fibrillation) known to be associated more specifically with embolism than MI. Eight of 27 CIs (30%) with CT scans had hemorrhagic transformation of varying degrees; 5 were symptomatic.
CONCLUSIONS: The time of occurrence and sites of CI after rt-PA and heparin therapy for acute MI are similar to those reported during the prethrombolytic era.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183334     DOI: 10.1161/01.str.28.6.1107

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  2 in total

1.  Antithrombotic medication for cardioembolic stroke prevention.

Authors:  M Àngels Font; Jerzy Krupinski; Adrià Arboix
Journal:  Stroke Res Treat       Date:  2011-06-22

2.  Ischemic stroke complicating thrombolytic therapy with tenecteplase for ST elevation myocardial infarction: two case reports.

Authors:  Salim Arous; Meryem Haboub; Mohamed El Ghali Benouna; Tarik Bentaoune; Rachida Habbal
Journal:  J Med Case Rep       Date:  2017-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.